Alzheimer´s Disease Clinical Trial
Official title:
A Randomized, Controlled, Parallel Group, Double-blind, Multi-centre, Phase IIb Study to Assess Safety and Clinical Activity of Continued AFFITOPE® AD02 Vaccinations of Patients Who Participated in the AFFITOPE® AD02 Phase II Study AFF006.
This is a follow-up study to assess safety and clinical activity of continued AFFITOPE® AD02 vaccinations in patients with Alzheimer's disease. Patients, who have already participated in AFF006 will be involved in 27 study sites in Europe. Duration of patient's participation in the clinical trial is 19 months.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT02245737 -
An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease
|
Phase 2/Phase 3 | |
Completed |
NCT02360527 -
Retinal Neurodegeneration in Type 2 Diabetes as Biomarker for Alzheimer´s Disease
|
N/A | |
Completed |
NCT01225809 -
AD01 Follow up Extension Visit
|
N/A | |
Terminated |
NCT01117948 -
Efficacy and Safety of Lornoxicam in Patients With Mild to Moderate Probable Alzheimer´s Disease.
|
Phase 2 | |
Terminated |
NCT01736579 -
Long-Term Study of IGIV, 10% in Alzheimer´s Disease
|
Phase 3 | |
Completed |
NCT02501876 -
Type 2 Diabetes Mellitus as Catalyst for Alzheimer's Disease
|
N/A | |
Active, not recruiting |
NCT01695889 -
Is There a Relationship Between Previous Exposure to General Anesthesia and the Development of Alzheimer´s Disease?
|
N/A | |
Completed |
NCT00608946 -
Treatment With Copper in Patients With Mild Alzheimer´s Dementia
|
Phase 2 | |
Completed |
NCT02224326 -
Vagus Somatosensory Evoked Potentials and Near-infrared Spectroscopy in the Early Diagnosis of Dementia
|
||
Terminated |
NCT01125683 -
To Evaluate Effects of AZD1446, Placebo and Donepezil in Patients With Alzheimer's Disease
|
Phase 2 | |
Terminated |
NCT01357629 -
Observational Follow-up Extension Study of AFF002 and AFF004A in Patients With Alzheimer's Disease
|
N/A | |
Terminated |
NCT01524887 -
Phase 3 IGIV, 10% in Alzheimer´s Disease
|
Phase 3 | |
Completed |
NCT00692705 -
Positron Emission Tomography (PET) Study With [11C]AZD2995 and [11C]AZD2184, Candidate PET Ligands for β Amyloid
|
Phase 1 | |
Active, not recruiting |
NCT02623764 -
EEG-cholinergic Index and Clinical Response to Treatment With Cholinesterase Inhibitors
|
||
Completed |
NCT00948259 -
Safety Study of a Glycogen Synthase Kinase 3 (GSK3) Inhibitor in Patients With Alzheimer´s Disease
|
Phase 1/Phase 2 | |
Completed |
NCT00818662 -
A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease
|
Phase 3 |